These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32228149)

  • 1.
    Endo M; Nabhan F; Angell TE; Harrell RM; Nasr C; Wei S; Sipos JA
    Thyroid; 2020 Sep; 30(9):1390-1392. PubMed ID: 32228149
    [No Abstract]   [Full Text] [Related]  

  • 2. Unraveling Hürthle cell lesions of the thyroid using molecular findings.
    Wong KS
    Cancer Cytopathol; 2022 Jun; 130(6):405-406. PubMed ID: 35285577
    [No Abstract]   [Full Text] [Related]  

  • 3. The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease.
    Kauffmann PR; Dejax C; de Latour M; Dauplat J
    Eur J Surg Oncol; 2004 Sep; 30(7):786-9. PubMed ID: 15296995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
    Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
    Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hürthle cell cytology.
    Raghunathan R; Longstaff XR; Hughes EG; Li SJ; Sant VR; Tseng CH; Rao J; Wu JX; Yeh MW; Livhits MJ
    Surgery; 2024 Jan; 175(1):221-227. PubMed ID: 37926582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of malignancy in patients with a thyroid nodule that contains Hürthle cells.
    Turanli S; Pirhan Y; Ozcelik CK; Cetin A
    Otolaryngol Head Neck Surg; 2011 Apr; 144(4):514-7. PubMed ID: 21493226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in Cytology Specimens With Hürthle Cells.
    Thodou E; Canberk S; Schmitt F
    Front Endocrinol (Lausanne); 2021; 12():701877. PubMed ID: 34248855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indeterminate Thyroid Nodules and Advances in Molecular Pathology.
    Belovarac B; Zhou F; Sharma J; Brandler TC
    Semin Diagn Pathol; 2023 Sep; 40(5):349-352. PubMed ID: 37173165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspiration cytology of thyroid nodules with Hürthle cells: cytomorphologic predictors for neoplasms, improving diagnostic accuracy and overcoming pitfalls.
    Kasper KA; Stewart J; Das K
    Acta Cytol; 2014; 58(2):145-52. PubMed ID: 24525356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
    Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
    J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
    Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
    Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
    Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle aspiration cytology of adrenal lesions classified with the Bethesda-like system: A retrospective study of 484 cases.
    Mustafa M; Cramer HM; Wu HH
    Diagn Cytopathol; 2020 Jul; 48(7):618-622. PubMed ID: 32348013
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
    Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
    Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in cytology: Fine needle aspiration cytology of BRAF
    Xing MH; van den Akker T; Gonzalez-Velazquez C; Urken ML; Chen H
    Diagn Cytopathol; 2021 Jan; 49(1):150-152. PubMed ID: 32681762
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule.
    Kang G; Cho EY; Shin JH; Chung JH; Kim JW; Oh YL
    Cancer Cytopathol; 2012 Feb; 120(1):44-51. PubMed ID: 21751431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.